-
models for pre-clinical validation. The tasks associated with this position will involve but are not limited to: Establishing of organoid lines from patient samples and cultivating cancer cell lines
-
to: • Establishing of organoid lines from patient samples and cultivating cancer cell lines • Conduct in vivo experiments. • Performing DNA, RNA and protein analysis of cancer cell lines, patient-derived organoids and
-
: Veterinary Medicine | Veterinary Biosciences A post-doctoral position is available for a highly motivated individual with a background in biochemistry, cell and/or molecular biology. We are interested in
-
, innovation, and unwavering commitment to confronting the scourge of cancer. At the heart of our endeavors is Dr. Elshad Hasanovs laboratory, with its razor-sharp focus on genitourinary malignancies, renal cell
-
research on microbial metabolism of environmental chemicals, involving microbial culture, urothelial cell tissue culture, and mouse model studies. The scholar awardee will participate in the President's
-
information on the lab, please visit our website: www.thehuanglab.net . Qualifications 1. The candidate must have a Ph.D. degree by the time of hire in plant molecular biology, cell biology, plant genetics
-
postdoctoral scholar position. We are looking for a skilled and highly motivated postdoctoral scholar with expertise in biochemistry, cell biology, structural biology, biophysics or related areas to conduct
-
, including lipid and metabolic disorders desired; experience in in cell signaling pathways and prior training in biochemistry, cellular and molecular biology is preferred; scientific publication record desired
-
Details Posted: 20-Jan-24 Type: Full-time Salary: Open Categories: Other Staff/Administrative Staff/Administrative Internal Number: R94793 The Post Doctoral Scholar will specialize in single-cell
-
University. Key Responsibilities: Participate in planning, designing, and managing research projects in translational cancer research with a focus on the antibody, CAR-NK and CAR-T cell immunotherapy